- Home
- SHMD vs LXEO Comparison
SHMD vs LXEO Comparison
Compare SHMD & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHMD
- LXEO
- Stock Information
- Founded
- SHMD 1864
- LXEO 2017
- Country
- SHMD Germany
- LXEO United States
- Employees
- SHMD N/A
- LXEO 72
- Industry
- SHMD
- LXEO
- Sector
- SHMD
- LXEO
- Exchange
- SHMD Nasdaq
- LXEO Nasdaq
- Market Cap
- SHMD 135.6M
- LXEO 154.0M
- IPO Year
- SHMD N/A
- LXEO 2023
- Fundamental
- Price
- SHMD $3.36
- LXEO $2.69
- Analyst Decision
- SHMD
- LXEO Strong Buy
- Analyst Count
- SHMD 0
- LXEO 5
- Target Price
- SHMD N/A
- LXEO $22.20
- AVG Volume (30 Days)
- SHMD 26.6K
- LXEO 892.8K
- Earning Date
- SHMD 02-25-2025
- LXEO 05-20-2025
- Dividend Yield
- SHMD N/A
- LXEO N/A
- EPS Growth
- SHMD 1309.32
- LXEO N/A
- EPS
- SHMD 1.07
- LXEO N/A
- Revenue
- SHMD $99,752,404.00
- LXEO N/A
- Revenue This Year
- SHMD N/A
- LXEO N/A
- Revenue Next Year
- SHMD N/A
- LXEO N/A
- P/E Ratio
- SHMD $3.08
- LXEO N/A
- Revenue Growth
- SHMD N/A
- LXEO N/A
- 52 Week Low
- SHMD $1.86
- LXEO $1.45
- 52 Week High
- SHMD $5.45
- LXEO $19.50
- Technical
- Relative Strength Index (RSI)
- SHMD N/A
- LXEO 41.96
- Support Level
- SHMD N/A
- LXEO $2.77
- Resistance Level
- SHMD N/A
- LXEO $3.35
- Average True Range (ATR)
- SHMD 0.00
- LXEO 0.62
- MACD
- SHMD 0.00
- LXEO -0.09
- Stochastic Oscillator
- SHMD 0.00
- LXEO 0.69
About SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.